Ticker: DNLI

Company: Denali Therapeutics Inc.

Person: Alexander O Schuth, officer

Transaction date: Jan. 6, 2026

Reporting date: Jan. 8, 2026

Average share price: 16.5

Sold 17218.0 shares for 284097.0